Irbesartan Related Compound A

1-(Pentanoylamino)-N-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}cyclopentancarboxamid

1-(Pentanoylamino)-N-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}cyclopentanecarboxamide

1-(Pentanoylamino)-N-{[2′-(1H-tétrazol-5-yl)-4-biphénylyl]méthyl}cyclopentanecarboxamide

1-[(1-Oxopentyl)amino]-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]cyclopentanecarboxamide

748812-53-5

Cyclopentanecarboxamide, 1-[(1-oxopentyl)amino]-N-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-

Irbesartan Related Compound A

MFCD22380598

VC4PBS252C

1-(Pentanoylamino)-N-((2′-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)cyclopentanecarboxamide

1-(Pentanoylamino)-N-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]cyclopentanecarboxamide

1-(pentanoylamino)-N-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]cyclopentane-1-carboxamide

1-(pentanoylamino)-N-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]cyclopentanecarboxamide

1-(pentanoylamino)-N-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]cyclopentane-1-carboxamide

1-(pentanoylamino)-N-{[2′-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}cyclopentanecarboxamide

1-pentanamido-N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)cyclopentane-1-carboxamide

1-pentanamido-N-{[2′-(2H-1,2,3,4-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl]methyl}cyclopentane-1-carboxamide

1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2′-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE

Cyclopentanecarboxamide, 1-[(1-oxopentyl)amino]-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-

Irbesartan Related Compound A(1-pentanoylamino-cyclopentanecarboxylic acid [2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide)

n-((2-(1h-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-1-pentanamidocyclopentanecarboxamide

n-((2-(1h-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-1-pentanamidocyclopentanecarboxamide(wxc02361)

N-((2′-(1H-Tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-1-pentanamidocyclopentanecarboxamide

N-((2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-1-pentanamidocyclopentane-1-carboxamide